Patents by Inventor Rachel Y. Labell

Rachel Y. Labell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LIQUID FORMULATIONS OF BENDAMUSTINE
    Publication number: 20210113530
    Abstract: Stable liquid formulations of bendamustine, and pharmaceutically acceptable salts thereof, and polar aprotic solvents, are described.
    Type: Application
    Filed: September 9, 2020
    Publication date: April 22, 2021
    Inventors: Anthony S. Drager, Rachel Y. LaBell, Piyush R. Patel
  • LIQUID FORMULATIONS OF BENDAMUSTINE
    Publication number: 20210008035
    Abstract: Stable liquid formulations of bendamustine, and pharmaceutically acceptable salts thereof, and polar aprotic solvents, are described.
    Type: Application
    Filed: March 31, 2020
    Publication date: January 14, 2021
    Inventors: Anthony S. Drager, Rachel Y. LaBell, Piyush R. Patel
  • BENDAMUSTINE DERIVATIVES AND METHODS OF USING SAME
    Publication number: 20180147186
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Application
    Filed: January 24, 2018
    Publication date: May 31, 2018
    Applicant: IGNYTA, INC.
    Inventors: Roger P. BAKALE, Peter D. BROWN, Jian CHEN, Anthony S. DRAGER, Rachel Y. LABELL, Robert E. MCKEAN, Piyush R. PATEL, Renee C. ROEMMELE
  • LIQUID FORMULATIONS OF BENDAMUSTINE
    Publication number: 20180125824
    Abstract: Stable liquid formulations of bendamustine, and pharmaceutically acceptable salts thereof, and polar aprotic solvents, are described.
    Type: Application
    Filed: August 28, 2017
    Publication date: May 10, 2018
    Inventors: Anthony S. Drager, Rachel Y. LaBell, Piyush R. Patel
  • Bendamustine derivatives and methods of using same
    Patent number: 9913827
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Grant
    Filed: March 10, 2017
    Date of Patent: March 13, 2018
    Assignee: IGNYTA, INC.
    Inventors: Roger P. Bakale, Peter D. Brown, Jian Chen, Anthony S. Drager, Rachel Y. LaBell, Robert E. McKean, Piyush R. Patel, Renee C. Roemmele
  • BENDAMUSTINE DERIVATIVES AND METHODS OF USING SAME
    Publication number: 20170182008
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Application
    Filed: March 10, 2017
    Publication date: June 29, 2017
    Applicant: IGNYTA, INC.
    Inventors: Roger P. Bakale, Peter D. Brown, Jian Chen, Anthony S. Drager, Rachel Y. LaBell, Robert E. McKean, Piyush R. Patel, Renee C. Roemmele
  • Bendamustine derivatives and methods of using same
    Patent number: 9630926
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Grant
    Filed: June 16, 2016
    Date of Patent: April 25, 2017
    Assignee: IGNYTA, INC.
    Inventors: Roger P. Bakale, Peter D. Brown, Jian Chen, Anthony S. Drager, Rachel Y. LaBell, Robert E. McKean, Piyush R. Patel, Renee C. Roemmele
  • BENDAMUSTINE DERIVATIVES AND METHODS OF USING SAME
    Publication number: 20160289198
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Application
    Filed: June 16, 2016
    Publication date: October 6, 2016
    Applicant: Ignyta, Inc.
    Inventors: Roger P. BAKALE, Peter D. BROWN, Jian CHEN, Anthony S. DRAGER, Rachel Y. LABELL, Robert E. MCKEAN, Piyush R. PATEL, Renee C. ROEMMELE
  • Bendamustine derivatives and methods of using same
    Patent number: 9452988
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Grant
    Filed: November 12, 2013
    Date of Patent: September 27, 2016
    Assignee: Ignyta, Inc.
    Inventors: Roger P. Bakale, Peter D. Brown, Jian Chen, Anthony S. Drager, Rachel Y. Labell, Robert E. McKean, Piyush R. Patel, Renee C. Roemmele, Bradley McIntyre
  • BENDAMUSTINE DERIVATIVES AND METHODS OF USING SAME
    Publication number: 20160016912
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Application
    Filed: September 28, 2015
    Publication date: January 21, 2016
    Inventors: Roger P. BAKALE, Peter D. BROWN, Jian CHEN, Anthony S. DRAGER, Rachel Y. LABELL, Robert E. MCKEAN, Piyush R. PATEL, Renee C. ROEMMELE
  • Liquid Formulations of Bendamustine
    Publication number: 20150335750
    Abstract: Stable liquid formulations of bendamustine, and pharmaceutically acceptable salts thereof, and polar aprotic solvents, are described.
    Type: Application
    Filed: July 31, 2015
    Publication date: November 26, 2015
    Inventors: Anthony S. Drager, Rachel Y. LaBell, Piyush R. Patel
  • Bendamustine derivatives and methods of using same
    Patent number: 9150517
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Grant
    Filed: April 29, 2015
    Date of Patent: October 6, 2015
    Assignee: IGNYTA, INC.
    Inventors: Roger P. Bakale, Peter D. Brown, Jian Chen, Anthony S. Drager, Rachel Y. Labell, Robert E. McKean, Piyush R. Patel, Renee C. Roemmele
  • Bendamustine derivatives and methods of using same
    Patent number: 9149464
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Grant
    Filed: May 13, 2015
    Date of Patent: October 6, 2015
    Assignee: IGNYTA, INC.
    Inventors: Roger P. Bakale, Peter D. Brown, Jian Chen, Anthony S. Drager, Rachel Y. Labell, Robert E. McKean, Piyush R. Patel, Renee C. Roemmele
  • BENDAMUSTINE DERIVATIVES AND METHODS OF USING SAME
    Publication number: 20150274675
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Application
    Filed: November 12, 2013
    Publication date: October 1, 2015
    Inventors: Roger P. Bakale, Peter D. Brown, Jian Chen, Anthony S. Drager, Rachel Y. Labell, Robert E. McKean, Piyush R. Patel, Renee C. Roemmele
  • BENDAMUSTINE DERIVATIVES AND METHODS OF USING SAME
    Publication number: 20150246023
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Application
    Filed: May 13, 2015
    Publication date: September 3, 2015
    Inventors: Roger P. BAKALE, Peter D. BROWN, Jian CHEN, Anthony S. DRAGER, Rachel Y. LABELL, Robert E. MCKEAN, Piyush R. PATEL, Renee C. ROEMMELE
  • BENDAMUSTINE DERIVATIVES AND METHODS OF USING SAME
    Publication number: 20150232427
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Application
    Filed: April 29, 2015
    Publication date: August 20, 2015
    Inventors: Roger P. BAKALE, Peter D. BROWN, Jian CHEN, Anthony S. DRAGER, Rachel Y. LABELL, Robert E. MCKEAN, Piyush R. PATEL, Renee C. ROEMMELE
  • Liquid Formulations Of Bendamustine
    Publication number: 20140206733
    Abstract: Stable liquid formulations of bendamustine, and pharmaceutically acceptable salts thereof, and polar aprotic solvents, are described.
    Type: Application
    Filed: March 21, 2014
    Publication date: July 24, 2014
    Applicant: Cephalon, Inc.
    Inventors: Anthony S. Drager, Rachel Y. Labell, Piyush R. Patel
  • Liquid Formulations Of Bendamustine
    Publication number: 20140128443
    Abstract: Stable liquid formulations of bendamustine, and pharmaceutically acceptable salts thereof, and polar aprotic solvents, are described.
    Type: Application
    Filed: January 9, 2014
    Publication date: May 8, 2014
    Applicant: Cephalon, Inc.
    Inventors: Anthony S. Drager, Rachel Y. LaBell, Piyush R. Patel
  • Liquid Formulations of Bendamustine
    Publication number: 20140080881
    Abstract: Stable liquid formulations of bendamustine, and pharmaceutically acceptable salts thereof, and polar aprotic solvents, are described.
    Type: Application
    Filed: November 20, 2013
    Publication date: March 20, 2014
    Applicant: Cephalon, Inc.
    Inventors: Anthony S. Drager, Rachel Y. LaBell, Piyush R. Patel
  • Liquid Formulations Of Bendamustine
    Publication number: 20130041004
    Abstract: Stable liquid formulations of bendamustine, and pharmaceutically acceptable salts thereof, and polar aprotic solvents, are described.
    Type: Application
    Filed: October 19, 2012
    Publication date: February 14, 2013
    Inventors: Anthony S. Drager, Rachel Y. LaBell, Piyush R. Patel